Since our results demonstrated a greatly increased percentage of CXCR3-expressing CD4+ T cells in CSF from MS patients, the percentage of CXCR3-expressing CD8+ T cells in CSF was relatively low, as in blood. The gene discussed is CD8A; the disease is myeloid sarcoma.